More Galleries
7 hot businesses to start now It's hard to predict what businesses will take off, but these startup ideas have been drawing tons of interest from entrepreneurs and their customers on Thumbtack.com. More
How will a minimum wage hike hit businesses? Thirteen states increased the minimum wage on Jan. 1, and President Obama supports raising the federal rate to $10.10. 4 small business owners weigh in on how an increase would affect them. More
America's favorite businesses From a science camp for girls to a kombucha brewer, communities around the country voted on their favorite small businesses. These 12 came out on top, each scoring a $250,000 grant from Chase and a trip to Google's headquarters. More

Special Offer
3 of 36
BACK NEXT
3rd place: How to live forever
3rd place: How to live forever
Raymond Sekula and Sasha Bakhru
Team name: NeuroBank

School: Carnegie Mellon University, Tepper School of Business

Team members: Raymond Sekula, Sasha Bakhru

Concept: NeuroBank plans to use proprietary technology to isolate, purify, expand and store adult neural stem cells. The company, through its product NeuroBank, will tap into the market of neurologic disease sufferers who wish to harvest and store their neural stem cells before they deteriorate in quantity or quality due to age or disease.

Therapies that could use such cells to treat diseases such as strokes, epilepsy, multiple sclerosis and more are still many years away. But NeuroBank believes that 13.6 million people currently suffer from illnesses that could be cured using neural stem cells, creating a $4-billion market opportunity for cell storage.

In exchange for each customer's initiation fee, NeuroBank will provide a kit that will allow partner physicians to isolate the neural stem cells. The cells will then be shipped to NeuroBank's processing laboratories. Customers will also pay an annual storage fee. NeuroBank will provide customers with flexible monthly payment options.

The Carnegie-Mellon team is led by Raymond Sekula, a trained neurosurgeon, who is currently pursuing his MBA at Tepper. Dr. Sekula is the company's chief scientist and will also serve as initial CEO.

The company's business plan hinges on its proprietary technology. It is currently awaiting the results of patent applications filed in the U.S. and internationally.

Timeline: At the seed stage, NeuroBank plans to continue with research and expand its intellectual property portfolio. It will develop a commercial laboratory, and build a marketing network through insurance companies. - Candice Zachariahs

NEXT: 4th place: Wirelessly zapping pain

Last updated May 02 2008: 11:51 AM ET
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.